Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Triamcinolone hexacetonide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Triamcinolone hexacetonide 20mg/1ml inj ampoules
1001022Y0AAADAD
|
Triamcinolone hexacetonide | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | 211 |
|
Lederspan 100mg/5ml suspension for injection vials
1001022Y0BBACAC
|
Lederspan | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Lederspan 20mg/1ml suspension for injection vials
1001022Y0BBABAB
|
Lederspan | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Triamcinolone hexacetonide 100mg/5ml inj vials
1001022Y0AAACAC
|
Triamcinolone hexacetonide | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
|
Triamcinolone hexacetonide 20mg/1ml inj vials
1001022Y0AAABAB
|
Triamcinolone hexacetonide | Triamcinolone hexacetonide | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.